Evidence for an osteoblast-activating factor in a patient with peripheral T-cell lymphoma and osteosclerosis

Klin Wochenschr. 1989 Apr 3;67(7):402-7. doi: 10.1007/BF01711269.

Abstract

A patient with peripheral T-cell Lymphoma and acquired, systemic osteosclerosis is described. Bone histology showed a spectacular activation of osteoblasts accompanyed by massive new bone formation. Alkaline phosphatase in serum was elevated and increased to greater than 2000 U/l when the lymphoma became refractory to chemotherapy. In the patient's serum an osteoblast-activating factor could be demonstrated using a rat osteogenic osteosarcoma cell line (ROS 17/2.8). The factor was absent during remission of the tumor. We conclude that osteosclerosis was a paraneoplastic syndrome in this patient due to the secretion of an osteoblast-stimulating factor by the T-cell lymphoma. This situation is similar to the secretion of osteoclast-activating factors described in B-cell lymphomas, particularly multiple myeloma. The characterization of such a factor could be of therapeutic relevance.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Alkaline Phosphatase / blood
  • Animals
  • Bone Marrow / pathology
  • Bone Neoplasms / pathology
  • Bone and Bones / pathology
  • Cell Line
  • Humans
  • L-Lactate Dehydrogenase / blood
  • Lymphokines / blood*
  • Lymphoma, Non-Hodgkin / enzymology*
  • Lymphoma, Non-Hodgkin / pathology
  • Male
  • Osteosarcoma / pathology
  • Osteosclerosis / enzymology*
  • Paraneoplastic Syndromes / enzymology*
  • Paraneoplastic Syndromes / pathology
  • Rats
  • T-Lymphocytes*

Substances

  • Lymphokines
  • L-Lactate Dehydrogenase
  • Alkaline Phosphatase